I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fabisch, Christian
30
results:
Search for persons
X
Format
Online (27)
Print (3)
Mediatypes
E-Books (2)
Books (1)
Articles (Online) (10)
OpenAccess-fulltext (15)
more...
Thesis (2)
less...
Languages
german (5)
english (25)
Sorted by: Relevance
Sorted by: Year
?
1
Management and outcome of patients with chronic myeloid leu..:
Brioli, Annamaria
;
Lomaia, Elza
;
Fabisch, Christian
...
Leukemia. 38 (2024) 5 - p. 1072-1080 , 2024
Link:
https://doi.org/10.1038/..
?
2
P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERI..:
Birndt, Sebastian
;
Hammersen, Jakob
;
Döhner, Konstanze
...
HemaSphere. 7 (2023) S3 - p. e2130832 , 2023
Link:
https://doi.org/10.1097/..
?
3
S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCT..:
Hochhaus, Andreas
;
Burchert, Andreas
;
Saußele, Susanne
...
HemaSphere. 7 (2023) S3 - p. e4695659 , 2023
Link:
https://doi.org/10.1097/..
?
4
S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRO..:
Ernst, Thomas
;
Le Coutre, Philipp
;
Crysandt, Martina
...
HemaSphere. 7 (2023) S3 - p. e34543a6 , 2023
Link:
https://doi.org/10.1097/..
?
5
ASXL1 mutations predict inferior molecular response to nilo..:
Schönfeld, Lioba
;
Rinke, Jenny
;
Hinze, Anna
...
Leukemia. 36 (2022) 9 - p. 2242-2249 , 2022
Link:
https://doi.org/10.1038/..
?
6
Frailty impairs the feasibility of induction therapy but no..:
Brioli, Annamaria
;
Manz, Kirsi
;
Pfirrmann, Markus
...
Journal of Cancer Research and Clinical Oncology. 146 (2019) 3 - p. 749-759 , 2019
Link:
https://doi.org/10.1007/..
?
7
Therapie der chronischen myeloischen Leukämie:
Hochhaus, Andreas
;
Fabisch, Christian
;
Ernst, Thomas
Der Onkologe. 25 (2019) 11 - p. 971-984 , 2019
Link:
https://doi.org/10.1007/..
?
8
PTPRG and PTPRC modulate nilotinib response in chronic myel..:
Drube, Julia
;
Ernst, Thomas
;
Pfirrmann, Markus
...
Oncotarget. 9 (2018) 10 - p. 9442-9455 , 2018
Link:
https://doi.org/10.18632..
?
9
P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERI..:
Birndt, Sebastian
;
Hammersen, Jakob
;
Döhner, Konstanze
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430329/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
10
S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRO..:
Ernst, Thomas
;
Le Coutre, Philipp
;
Crysandt, Martina
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428460/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
11
S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCT..:
Hochhaus, Andreas
;
Burchert, Andreas
;
Saußele, Susanne
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428351/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
ASXL1 mutations predict inferior molecular response to nilo..:
Schönfeld, Lioba
;
Rinke, Jenny
;
Hinze, Anna
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417980/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
ASXL1 mutations predict inferior molecular response to nilo..:
Schönfeld, Lioba
;
Rinke, Jenny
;
Krause, Stefan W
...
info:eu-repo/semantics/altIdentifier/issn/0887-6924. , 2022
Link:
https://publications.rwt..
?
14
S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCT..:
Andreas Hochhaus
;
Andreas Burchert
;
Susanne Saußele
...
http://journals.lww.com/10.1097/01.HS9.0000967540.46956.59. , 2023
Link:
https://doi.org/10.1097/..
?
15
P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERI..:
Sebastian Birndt
;
Jakob Hammersen
;
Konstanze Döhner
...
http://journals.lww.com/10.1097/01.HS9.0000973044.21308.32. , 2023
Link:
https://doi.org/10.1097/..
1-15
Related subjects
Betriebliches Prüfungswesen
